Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV

With growing interest and efforts to achieve a hepatitis B (HBV) cure, HBV therapeutics have increasingly entered the clinical testing phase. In designing an early phase clinical trial aimed at HBV cure, the heterogeneity in participants and the choice of a biomarker endpoint that signals a cure req...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Minhee, Price, Jennifer C., Peters, Marion G., Lewin, Sharon R., Sulkowski, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514436/
https://www.ncbi.nlm.nih.gov/pubmed/37744732
http://dx.doi.org/10.1016/j.jve.2023.100344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514436/
https://www.ncbi.nlm.nih.gov/pubmed/37744732
http://dx.doi.org/10.1016/j.jve.2023.100344

Ejemplares similares